# Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)

> **NCT04446611** · NA · COMPLETED · sponsor: **Foundation for Professional Development (Pty) Ltd** · enrollment: 2247 (actual)

## Conditions studied

- Sexually Transmitted Infection
- HIV/AIDS
- Cost-effectiveness
- Birth Outcomes
- Vaginal Microbiome
- Neisseria Gonorrhoeae
- Chlamydia Trachomatis
- Trichomonas Vaginalis
- Antenatal Care
- Pregnancy

## Interventions

- **DIAGNOSTIC_TEST:** First antenatal care + test-of-cure
- **DIAGNOSTIC_TEST:** First antenatal care + week 30-34 gestation (no test-of-cure)

## Key facts

- **NCT ID:** NCT04446611
- **Lead sponsor:** Foundation for Professional Development (Pty) Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-29
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 2247 (ACTUAL)
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446611, "Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT04446611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
